Skip to Content

Notice

Advisory Committee; Renewals

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Deputy Commissioner of Food and Drugs (the Deputy Commissioner). The Deputy Commissioner has determined that it is in the public interest to renew the charters of the committees listed in the following table for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in the following table. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).

DATES:

Authority for these committees will expire on the dates indicated in the following table unless the Deputy Commissioner formally determines that renewal is in the public interest.

Name of committeeDate of ­expiration
Medical Imaging Drugs Advisory CommitteeFebruary 28, 2004
Gastrointestinal Drugs Advisory CommitteeMarch 3, 2004
Advisory Committee for Reproductive Health DrugsMarch 23, 2004
Arthritis Advisory ­CommitteeApril 5, 2004
Veterinary Medicine ­Advisory CommitteeApril 24, 2004
Anesthetic and Life ­Support Drugs ­Advisory CommitteeMay 1, 2004
Blood Products Advisory CommitteeMay 13, 2004
Pulmonary-Allergy Drugs Advisory ­CommitteeMay 30, 2004
Drug Safety and Risk Management Advisory Committee (formerly Drug Abuse Advisory Committee)May 31, 2004
Science Advisory Board/NCTRJune 2, 2004
Peripheral and Central Nervous System Drugs Advisory ­CommitteeJune 4, 2004
Psychopharmacologic Drugs Advisory ­CommitteeJune 4, 2004
Transmissible Spongiform Encephalopathies ­Advisory CommitteeJune 9, 2004
Start Further Info

FOR FURTHER INFORMATION CONTACT:

Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info Start Signature

Dated: July 5, 2002.

William K. Hubbard,

Senior Associate Commissioner for Policy, Planning, and Legislation.

End Signature End Preamble

[FR Doc. 02-17478 Filed 7-10-02; 8:45 am]

BILLING CODE 4160-01-S